2015 marks the 50th anniversary of the adoption of the first law on the authorisation of pharmaceuticals at EU level. This law set the basis for some of the key principles that are still valid today.
Over the past 50 years a large body of legislation has been developed around these principles, with the progressive harmonisation of requirements for the granting of marketing authorisations and post-marketing monitoring implemented across the entire EU.
To mark the 50th anniversary of the adoption of the first EU pharmaceutical law the European Commission organised a conference on 28 September 2015 to discuss the future role of EU pharmaceutical legislation in protecting the health of citizens in the EU and in the world, and in promoting advances in science, innovation and public health.
Although there have been many achievements to date, there are still many challenges ahead.
The conference brought to the surface different perspectives from representatives of national governments, European institutions, national competent authorities, industry, healthcare professionals, academia and patient groups, with the objective of working towards a shared vision for the future. EFA was represented by EU Policy and Membership Officer Jelena Malinina.
More information on event is available here: http://ec.europa.eu/health/human-use/50years/index_en.htm